Final answer:
In the Tylenol case, stakeholders such as consumers, the Johnson & Johnson company, retailers, medical professionals, regulators, and competitors in the pharmaceutical industry were all impacted in various ways by the crisis.
Step-by-step explanation:
The Tylenol case involves several key stakeholders who were affected by the events. Consumers of Tylenol products were directly affected due to safety concerns and potential health risks. The Johnson & Johnson company, as the manufacturer, faced a crisis that threatened their reputation and financial stability. Retailers experienced losses from removing the product from shelves and dealing with consumer fears.
Medical professionals had to address patient concerns and possibly alter prescriptions and treatment plans. Regulators and public health officials had to investigate the crisis and may have adjusted policies as a result. Lastly, competitors in the pharmaceutical industry may have experienced changes in market dynamics due to the incident. These parties all had different levels of impact and required a complex response from Johnson & Johnson to restore confidence in their products.